Medreich PLC UK has issued a recall notice for a batch of mebeverine hydrochloride 135mg film-coated tablets. It says that this is a precautionary measure, ‘due to out of specification results for tablet dissolution’ during routine product release testing.
Related Article: PCN funding increased to cover pay rise for ARRS pharmacists
It said that healthcare professionals must stop supplying batch B11539 immediately, quarantine all remaining stock and return it to their suppliers.
Related Article: Turning plastic waste into sustainable paracetamol
However, if patients have already been given medicines from this batch, they should continue to take it as prescribed.
The Medicines and Healthcare products Regulatory Agency said that there had been no reports of adverse reactions related to this issue, but that patients who experience adverse reactions or insufficient control of symptoms should seek medical attention, and report any suspected adverse reactions via the MHRA Yellow Card scheme.
Related Article: Generic launched to replace discontinued Otomize ear spray
Have your say
Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.